Angela F. McKoy, Ph.D. - Publications
Affiliations: | 2011 | Princeton University, Princeton, NJ |
Area:
Synthetic Biology and Alzheimer's DiseaseYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | McKoy AF, Chen J, Schupbach T, Hecht MH. Structure-activity relationships for a series of compounds that inhibit aggregation of the Alzheimer's peptide, Aβ42. Chemical Biology & Drug Design. 84: 505-12. PMID 24751138 DOI: 10.1111/Cbdd.12341 | 0.646 | |||
2012 | McKoy AF, Chen J, Schupbach T, Hecht MH. A novel inhibitor of amyloid β (Aβ) peptide aggregation: from high throughput screening to efficacy in an animal model of Alzheimer disease. The Journal of Biological Chemistry. 287: 38992-9000. PMID 22992731 DOI: 10.1074/Jbc.M112.348037 | 0.647 | |||
2011 | Armstrong AH, Chen J, McKoy AF, Hecht MH. Mutations that replace aromatic side chains promote aggregation of the Alzheimer's Aβ peptide. Biochemistry. 50: 4058-67. PMID 21513285 DOI: 10.1021/Bi200268W | 0.63 | |||
2011 | McKoy A, Hecht M. P2-481: A high throughput screen identifies compounds that inhibit Alzheimer's peptide aggregation and reduce toxicity in vitro and in drosophila melanogaster Alzheimer's & Dementia. 7: S466-S466. DOI: 10.1016/j.jalz.2011.05.1352 | 0.749 | |||
2010 | McKoy AF, Hecht M. P3-270: A high throughput screen identifies compounds that inhibit Abeta peptide aggregation and reduce Abeta toxicity in vitro and in drosophila melanogaster Alzheimer's & Dementia. 6: S531-S531. DOI: 10.1016/J.Jalz.2010.05.1770 | 0.749 | |||
Show low-probability matches. |